Global Intravenous Solutions Market Analysis and Forecast 2024-2030

Global Intravenous Solutions Market Analysis and Forecast 2024-2030


Summary

Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.

According to APO Research, The global Intravenous Solutions market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Intravenous Solutions is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Intravenous Solutions is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Intravenous Solutions is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Intravenous Solutions is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Intravenous Solutions include Baxter, Kelun Group, Fresenius Kabi, Otsuka, ICU Medical, Fresenius Kabi, JW Life Science and B. Braun Melsungen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Intravenous Solutions, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Intravenous Solutions, also provides the sales of main regions and countries. Of the upcoming market potential for Intravenous Solutions, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Intravenous Solutions sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Intravenous Solutions market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Intravenous Solutions sales, projected growth trends, production technology, application and end-user industry.

Intravenous Solutions segment by Company

Baxter
Kelun Group
Fresenius Kabi
Otsuka
ICU Medical
Fresenius Kabi
JW Life Science
B. Braun Melsungen
Intravenous Solutions segment by Type

Crystalloids
Colloids
Others
Intravenous Solutions segment by Application

Basic IV Solutions
Nutrient Infusion Solution
Others
Intravenous Solutions segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Intravenous Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Solutions.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Intravenous Solutions in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Intravenous Solutions manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intravenous Solutions sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Intravenous Solutions Market by Type
1.2.1 Global Intravenous Solutions Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Crystalloids
1.2.3 Colloids
1.2.4 Others
1.3 Intravenous Solutions Market by Application
1.3.1 Global Intravenous Solutions Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Basic IV Solutions
1.3.3 Nutrient Infusion Solution
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Intravenous Solutions Market Dynamics
2.1 Intravenous Solutions Industry Trends
2.2 Intravenous Solutions Industry Drivers
2.3 Intravenous Solutions Industry Opportunities and Challenges
2.4 Intravenous Solutions Industry Restraints
3 Global Market Growth Prospects
3.1 Global Intravenous Solutions Revenue Estimates and Forecasts (2019-2030)
3.2 Global Intravenous Solutions Revenue by Region
3.2.1 Global Intravenous Solutions Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Intravenous Solutions Revenue by Region (2019-2024)
3.2.3 Global Intravenous Solutions Revenue by Region (2025-2030)
3.2.4 Global Intravenous Solutions Revenue Market Share by Region (2019-2030)
3.3 Global Intravenous Solutions Sales Estimates and Forecasts 2019-2030
3.4 Global Intravenous Solutions Sales by Region
3.4.1 Global Intravenous Solutions Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Intravenous Solutions Sales by Region (2019-2024)
3.4.3 Global Intravenous Solutions Sales by Region (2025-2030)
3.4.4 Global Intravenous Solutions Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Intravenous Solutions Revenue by Manufacturers
4.1.1 Global Intravenous Solutions Revenue by Manufacturers (2019-2024)
4.1.2 Global Intravenous Solutions Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Intravenous Solutions Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Intravenous Solutions Sales by Manufacturers
4.2.1 Global Intravenous Solutions Sales by Manufacturers (2019-2024)
4.2.2 Global Intravenous Solutions Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Intravenous Solutions Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Intravenous Solutions Sales Price by Manufacturers (2019-2024)
4.4 Global Intravenous Solutions Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Intravenous Solutions Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Intravenous Solutions Manufacturers, Product Type & Application
4.7 Global Intravenous Solutions Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Intravenous Solutions Market CR5 and HHI
4.8.2 2023 Intravenous Solutions Tier 1, Tier 2, and Tier 3
5 Intravenous Solutions Market by Type
5.1 Global Intravenous Solutions Revenue by Type
5.1.1 Global Intravenous Solutions Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Intravenous Solutions Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Intravenous Solutions Revenue Market Share by Type (2019-2030)
5.2 Global Intravenous Solutions Sales by Type
5.2.1 Global Intravenous Solutions Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Intravenous Solutions Sales by Type (2019-2030) & (M Units)
5.2.3 Global Intravenous Solutions Sales Market Share by Type (2019-2030)
5.3 Global Intravenous Solutions Price by Type
6 Intravenous Solutions Market by Application
6.1 Global Intravenous Solutions Revenue by Application
6.1.1 Global Intravenous Solutions Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Intravenous Solutions Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Intravenous Solutions Revenue Market Share by Application (2019-2030)
6.2 Global Intravenous Solutions Sales by Application
6.2.1 Global Intravenous Solutions Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Intravenous Solutions Sales by Application (2019-2030) & (M Units)
6.2.3 Global Intravenous Solutions Sales Market Share by Application (2019-2030)
6.3 Global Intravenous Solutions Price by Application
7 Company Profiles
7.1 Baxter
7.1.1 Baxter Comapny Information
7.1.2 Baxter Business Overview
7.1.3 Baxter Intravenous Solutions Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Baxter Intravenous Solutions Product Portfolio
7.1.5 Baxter Recent Developments
7.2 Kelun Group
7.2.1 Kelun Group Comapny Information
7.2.2 Kelun Group Business Overview
7.2.3 Kelun Group Intravenous Solutions Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Kelun Group Intravenous Solutions Product Portfolio
7.2.5 Kelun Group Recent Developments
7.3 Fresenius Kabi
7.3.1 Fresenius Kabi Comapny Information
7.3.2 Fresenius Kabi Business Overview
7.3.3 Fresenius Kabi Intravenous Solutions Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Fresenius Kabi Intravenous Solutions Product Portfolio
7.3.5 Fresenius Kabi Recent Developments
7.4 Otsuka
7.4.1 Otsuka Comapny Information
7.4.2 Otsuka Business Overview
7.4.3 Otsuka Intravenous Solutions Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Otsuka Intravenous Solutions Product Portfolio
7.4.5 Otsuka Recent Developments
7.5 ICU Medical
7.5.1 ICU Medical Comapny Information
7.5.2 ICU Medical Business Overview
7.5.3 ICU Medical Intravenous Solutions Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 ICU Medical Intravenous Solutions Product Portfolio
7.5.5 ICU Medical Recent Developments
7.6 Fresenius Kabi
7.6.1 Fresenius Kabi Comapny Information
7.6.2 Fresenius Kabi Business Overview
7.6.3 Fresenius Kabi Intravenous Solutions Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Fresenius Kabi Intravenous Solutions Product Portfolio
7.6.5 Fresenius Kabi Recent Developments
7.7 JW Life Science
7.7.1 JW Life Science Comapny Information
7.7.2 JW Life Science Business Overview
7.7.3 JW Life Science Intravenous Solutions Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 JW Life Science Intravenous Solutions Product Portfolio
7.7.5 JW Life Science Recent Developments
7.8 B. Braun Melsungen
7.8.1 B. Braun Melsungen Comapny Information
7.8.2 B. Braun Melsungen Business Overview
7.8.3 B. Braun Melsungen Intravenous Solutions Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 B. Braun Melsungen Intravenous Solutions Product Portfolio
7.8.5 B. Braun Melsungen Recent Developments
8 North America
8.1 North America Intravenous Solutions Market Size by Type
8.1.1 North America Intravenous Solutions Revenue by Type (2019-2030)
8.1.2 North America Intravenous Solutions Sales by Type (2019-2030)
8.1.3 North America Intravenous Solutions Price by Type (2019-2030)
8.2 North America Intravenous Solutions Market Size by Application
8.2.1 North America Intravenous Solutions Revenue by Application (2019-2030)
8.2.2 North America Intravenous Solutions Sales by Application (2019-2030)
8.2.3 North America Intravenous Solutions Price by Application (2019-2030)
8.3 North America Intravenous Solutions Market Size by Country
8.3.1 North America Intravenous Solutions Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Intravenous Solutions Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Intravenous Solutions Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 Europe
9.1 Europe Intravenous Solutions Market Size by Type
9.1.1 Europe Intravenous Solutions Revenue by Type (2019-2030)
9.1.2 Europe Intravenous Solutions Sales by Type (2019-2030)
9.1.3 Europe Intravenous Solutions Price by Type (2019-2030)
9.2 Europe Intravenous Solutions Market Size by Application
9.2.1 Europe Intravenous Solutions Revenue by Application (2019-2030)
9.2.2 Europe Intravenous Solutions Sales by Application (2019-2030)
9.2.3 Europe Intravenous Solutions Price by Application (2019-2030)
9.3 Europe Intravenous Solutions Market Size by Country
9.3.1 Europe Intravenous Solutions Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Intravenous Solutions Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Intravenous Solutions Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Intravenous Solutions Market Size by Type
10.1.1 China Intravenous Solutions Revenue by Type (2019-2030)
10.1.2 China Intravenous Solutions Sales by Type (2019-2030)
10.1.3 China Intravenous Solutions Price by Type (2019-2030)
10.2 China Intravenous Solutions Market Size by Application
10.2.1 China Intravenous Solutions Revenue by Application (2019-2030)
10.2.2 China Intravenous Solutions Sales by Application (2019-2030)
10.2.3 China Intravenous Solutions Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Intravenous Solutions Market Size by Type
11.1.1 Asia Intravenous Solutions Revenue by Type (2019-2030)
11.1.2 Asia Intravenous Solutions Sales by Type (2019-2030)
11.1.3 Asia Intravenous Solutions Price by Type (2019-2030)
11.2 Asia Intravenous Solutions Market Size by Application
11.2.1 Asia Intravenous Solutions Revenue by Application (2019-2030)
11.2.2 Asia Intravenous Solutions Sales by Application (2019-2030)
11.2.3 Asia Intravenous Solutions Price by Application (2019-2030)
11.3 Asia Intravenous Solutions Market Size by Country
11.3.1 Asia Intravenous Solutions Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Intravenous Solutions Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Intravenous Solutions Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Intravenous Solutions Market Size by Type
12.1.1 MEALA Intravenous Solutions Revenue by Type (2019-2030)
12.1.2 MEALA Intravenous Solutions Sales by Type (2019-2030)
12.1.3 MEALA Intravenous Solutions Price by Type (2019-2030)
12.2 MEALA Intravenous Solutions Market Size by Application
12.2.1 MEALA Intravenous Solutions Revenue by Application (2019-2030)
12.2.2 MEALA Intravenous Solutions Sales by Application (2019-2030)
12.2.3 MEALA Intravenous Solutions Price by Application (2019-2030)
12.3 MEALA Intravenous Solutions Market Size by Country
12.3.1 MEALA Intravenous Solutions Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Intravenous Solutions Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Intravenous Solutions Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Intravenous Solutions Value Chain Analysis
13.1.1 Intravenous Solutions Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Intravenous Solutions Production Mode & Process
13.2 Intravenous Solutions Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Intravenous Solutions Distributors
13.2.3 Intravenous Solutions Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings